Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Brandes Investment Partners LP

Brandes Investment Partners LP reduced its position in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 19.6% in the 4th quarter, HoldingsChannel.com reports. The firm owned 151,045 shares of the company’s stock after selling 36,768 shares during the quarter. Brandes Investment Partners LP’s holdings in Prestige Consumer Healthcare were worth $11,795,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. JPMorgan Chase & Co. raised its position in Prestige Consumer Healthcare by 3.2% during the third quarter. JPMorgan Chase & Co. now owns 272,255 shares of the company’s stock worth $19,630,000 after acquiring an additional 8,533 shares during the period. Geode Capital Management LLC raised its position in Prestige Consumer Healthcare by 4.0% during the third quarter. Geode Capital Management LLC now owns 1,326,794 shares of the company’s stock worth $95,678,000 after acquiring an additional 50,961 shares during the period. Avior Wealth Management LLC raised its position in Prestige Consumer Healthcare by 1,570.7% during the fourth quarter. Avior Wealth Management LLC now owns 8,554 shares of the company’s stock worth $668,000 after acquiring an additional 8,042 shares during the period. Barclays PLC raised its position in Prestige Consumer Healthcare by 346.3% during the third quarter. Barclays PLC now owns 92,444 shares of the company’s stock worth $6,665,000 after acquiring an additional 71,730 shares during the period. Finally, Assenagon Asset Management S.A. raised its position in Prestige Consumer Healthcare by 171.6% during the fourth quarter. Assenagon Asset Management S.A. now owns 46,931 shares of the company’s stock worth $3,665,000 after acquiring an additional 29,649 shares during the period. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Trading Up 1.1 %

Shares of PBH opened at $83.77 on Friday. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56. Prestige Consumer Healthcare Inc. has a 12-month low of $62.35 and a 12-month high of $90.04. The firm has a 50-day moving average price of $81.47 and a 200 day moving average price of $78.27. The firm has a market capitalization of $4.15 billion, a P/E ratio of 19.62, a P/E/G ratio of 2.69 and a beta of 0.46.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. Sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Analyst Upgrades and Downgrades

PBH has been the subject of a number of research analyst reports. Canaccord Genuity Group upped their price objective on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Raymond James upgraded shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research report on Thursday, December 19th. Oppenheimer increased their target price on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a research report on Thursday, February 13th. DA Davidson increased their target price on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a research report on Friday, February 7th. Finally, StockNews.com cut shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research report on Monday, March 10th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $92.60.

Insiders Place Their Bets

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of the stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $90.00, for a total transaction of $151,020.00. Following the completion of the transaction, the senior vice president now owns 17,157 shares of the company’s stock, valued at $1,544,130. This trade represents a 8.91 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.60% of the stock is currently owned by insiders.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.